[FG] Christ-Crain Mirjam

Atila, Cihan et al. (2025) ‘Relationship between plasma urea and copeptin in response to arginine stimulation in healthy adults, patients with vasopressin deficiency and primary polydipsia’, Pituitary, 28(1). Available at: https://doi.org/10.1007/s11102-024-01489-7.

Asla, Queralt et al. (2025) ‘Oxytocin levels in response to CRH administration in hypopituitarism and hypothalamic damage: a randomized, crossover, placebo-controlled trial’, Scientific reports, 15, p. 2360. Available at: https://doi.org/10.1038/s41598-025-86566-y.

Newell-Price, John et al. (2025) ‘Approach to the Patient With Suspected Hypotonic Polyuria’, Journal of Clinical Endocrinology and Metabolism, 110, pp. e506–e514. Available at: https://doi.org/10.1210/clinem/dgae565.

Perrild, Hans et al. (2025) ‘Postgraduate training and continuous medical education in endocrinology in Europe’, European Journal of Endocrinology, 192, pp. C1–C4. Available at: https://doi.org/10.1093/ejendo/lvae169.

Smit, J.M. et al. (2025) ‘Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials’, The Lancet Respiratory Medicine [Preprint]. Available at: https://doi.org/10.1016/S2213-2600(24)00405-3.

Atila, Cihan et al. (2024) ‘Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia: A Secondary Analysis of 4 Randomized Clinical Trials’, JAMA Network Open, 7(11). Available at: https://doi.org/10.1001/jamanetworkopen.2024.45278.

Wälchli-Popovic, Milica et al. (2024) ‘Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome—the FertIL trial’, Frontiers in Endocrinology. 11.09.2024, 15. Available at: https://doi.org/10.3389/fendo.2024.1435698.

Lengsfeld, S. et al. (2024) ‘Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study’, eBioMedicine, 107. Available at: https://doi.org/10.1016/j.ebiom.2024.105284.

Lamback, E. et al. (2024) ‘Extraventricular Neurocytoma of the Sellar Region Presenting With Syndrome of Inappropriate Antidiuresis’, JCEM Case Reports, 2(9). Available at: https://doi.org/10.1210/jcemcr/luae099.

Pelouto, A. et al. (2024) ‘Clinical factors associated with hyponatremia correction during treatment with oral urea’, Nephrology Dialysis Transplantation [Preprint]. Available at: https://doi.org/10.1093/ndt/gfae164.

Fleseriu, M. et al. (2024) ‘Hypopituitarism’, The Lancet, 403(10444), pp. 2632–2648. Available at: https://doi.org/10.1016/s0140-6736(24)00342-8.

Ebrahimi, Fahim, Andereggen, Lukas and Christ, Emanuel R. (2024) ‘Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management’, Reviews in Endocrine and Metabolic Disorders, 25(3), pp. 599–608. Available at: https://doi.org/10.1007/s11154-024-09888-8.

Rasiah, Roshaani et al. (2024) ‘Hospital Outcomes in Medical Patients With Alcohol-Related and Non–Alcohol-Related Wernicke Encephalopathy’, Mayo Clinic Proceedings, 99(5), pp. 740–753. Available at: https://doi.org/10.1016/j.mayocp.2023.07.021.

Schelldorfer, Andreas et al. (2024) ‘Rate of cardiovascular events up to 8 years after uncomplicated myocarditis: a nationwide cohort study’, European Heart Journal: Acute Cardiovascular Care, 13(5), pp. 401–410. Available at: https://doi.org/10.1093/ehjacc/zuae021.

Lüthi, Hualin et al. (2024) ‘Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial’, eClinicalMedicine, 68, p. 102429. Available at: https://doi.org/10.1016/j.eclinm.2024.102429.

Refardt, Julie, Vogt, Deborah R. and Christ-Crain, Mirjam (2024) ‘Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency’, New England Journal of Medicine, 390(3), pp. 288–290. Available at: https://doi.org/10.1056/NEJMc2314326.

Atila, Cihan et al. (2024) ‘Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls’, European Journal of Endocrinology, 190, pp. 354–362. Available at: https://doi.org/10.1093/ejendo/lvae040.

Atila, Cihan et al. (2024) ‘Plasma oxytocin levels in response to glucagon in patients with arginine vasopressin deficiency (central diabetes insipidus) and healthy controls’, Endocrine, 86, pp. 774–781. Available at: https://doi.org/10.1007/s12020-024-03920-2.

Atila, Cihan, Refardt, Julie and Christ-Crain, Mirjam (2024) ‘Correction to: Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency (Nature Reviews Endocrinology, (2024), 10.1038/s41574-024-00985-x)’, Nature Reviews Endocrinology [Preprint]. Available at: https://doi.org/10.1038/s41574-024-00998-6.

Atila, Cihan, Refardt, Julie and Christ-Crain, Mirjam (2024) ‘Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency’, Nature Reviews Endocrinology [Preprint]. Available at: https://doi.org/10.1038/s41574-024-00985-x.

Beck, Julia et al. (2024) ‘Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms’, Endocrine-Related Cancer, 31. Available at: https://doi.org/10.1530/erc-23-0235.

Bizzozero, Chiara Angela et al. (2024) ‘Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation tests’, European Journal of Endocrinology, 191, pp. 491–498. Available at: https://doi.org/10.1093/ejendo/lvae138.

Efthymiadis, Agathoklis et al. (2024) ‘Copeptin and the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery’, Endocrinology, Diabetes and Metabolism, 7(1). Available at: https://doi.org/10.1002/edm2.467.

Gregoriano, Claudia et al. (2024) ‘Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials’, BMC Cancer, 24. Available at: https://doi.org/10.1186/s12885-024-13160-2.

Hofland, Johannes et al. (2024) ‘Approach to the Patient: Insulinoma’, The Journal of clinical endocrinology and metabolism, 109, pp. 1109–1118. Available at: https://doi.org/10.1210/clinem/dgad641.

Huynh, Tony, Signal, Dana and Christ-Crain, Mirjam (2024) ‘Paediatric perspectives in the diagnosis of polyuria-polydipsia syndrome’, Clinical Endocrinology, null. Available at: https://doi.org/10.1111/cen.15011.

Karavitaki, Niki et al. (2024) ‘Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement’, Endocrine Reviews, 45, pp. 773–794. Available at: https://doi.org/10.1210/endrev/bnae023.

Kriemler, Lilian et al. (2024) ‘Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age’, European Stroke Journal, 9, pp. 494–500. Available at: https://doi.org/10.1177/23969873231221619.

Luger, Anton et al. (2024) ‘European Society of Endocrinology Curriculum and Training Recommendation in Endocrinology’, European Journal of Endocrinology, 191, pp. R71–R77. Available at: https://doi.org/10.1093/ejendo/lvae141.

Monnerat, Sophie et al. (2024) ‘Apelin and Copeptin Levels in Patients With Chronic SIAD Treated With Empagliflozin’, Journal of the Endocrine Society, 8. Available at: https://doi.org/10.1210/jendso/bvae106.

Radvanyi, Z. et al. (2024) ‘Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation’, Journal of Biological Chemistry, 300(1), p. 105480. Available at: https://doi.org/10.1016/j.jbc.2023.105480.

Sterns RH et al. (2024) ‘Treatment Guidelines for Hyponatremia Stay the Course’, Clinical Journal of the American Society of Nephrology, 19(1), pp. 129–135. Available at: https://doi.org/10.2215/CJN.0000000000000244.

Urwyler, Sandrine A et al. (2024) ‘Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study’, European Journal of Endocrinology, 190(1), pp. 113–120. Available at: https://doi.org/10.1093/ejendo/lvae003.

Baur, Fabienne et al. (2023) ‘Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: A predefined secondary analysis of a randomised trial’, BMJ Nutrition, Prevention and Health, 6(2), pp. 301–309. Available at: https://doi.org/10.1136/bmjnph-2023-000781.

Blum, Claudine A. et al. (2023) ‘Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial’, BMC Pulmonary Medicine, 23(1). Available at: https://doi.org/10.1186/s12890-023-02794-w.

Hepprich, Matthias, Ebrahimi, Fahim and Christ, Emanuel (2023) ‘Dyslipidaemia and growth hormone deficiency – A comprehensive review’, Best Practice and Research: Clinical Endocrinology and Metabolism, 37(6). Available at: https://doi.org/10.1016/j.beem.2023.101821.

Légeret, Corinne et al. (2023) ‘Prevalence of markers of beta cell autoimmunity and thyroid disease in children with coeliac disease’, BMC Pediatrics, 23(1). Available at: https://doi.org/10.1186/s12887-023-04294-6.

Lengsfeld, Sophia et al. (2023) ‘Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)—a structured summary of a study protocol for a randomized controlled study’, Trials, 24(1). Available at: https://doi.org/10.1186/s13063-023-07164-9.

Sailer CO et al. (2023) ‘Hypothalamic–pituitary–adrenal axis activity in patients with primary polydipsia compared to healthy controls’, Clinical Endocrinology, 99(6), pp. 535–544. Available at: https://doi.org/10.1111/cen.14835.

Borisov, Angel N. et al. (2023) ‘Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS’, Journal of Clinical Endocrinology and Metabolism, 108(11), pp. 2940–2949. Available at: https://doi.org/10.1210/clinem/dgad249.

Kutz, Alexander et al. (2023) ‘Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes’, Diabetes Care, 46(11), pp. 2004–2014. Available at: https://doi.org/10.2337/dc23-0671.

Monnerat S, Christ-Crain M and Refardt J (2023) ‘One Liter a Day, Keeps the Doctor Away’, 108(11). Available at: https://doi.org/10.1210/clinem/dgad217.

Smit, J.M. et al. (2023) ‘Predicting individualized treatment effects of corticosteroids in community-acquired-pneumonia: a data-driven analysis of randomized controlled trials’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2023.10.03.23296132.

Boesiger, Fabienne et al. (2023) ‘Changes in serum albumin concentrations over 7 days in medical inpatients with and without nutritional support. A secondary post-hoc analysis of a randomized clinical trial’, European Journal of Clinical Nutrition, 77(10), pp. 989–997. Available at: https://doi.org/10.1038/s41430-023-01303-w.

Monnerat S et al. (2023) ‘An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD’, Journal of Clinical Endocrinology and Metabolism, 108(10), pp. e1027–e1033. Available at: https://doi.org/10.1210/clinem/dgad238.

Warren AM et al. (2023) ‘Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management’, Endocrine Reviews, 44(5), pp. 819–861. Available at: https://doi.org/10.1210/endrev/bnad010.

Potasso, Laura et al. (2023) ‘Chloride and Potassium Assessment Is a Helpful Tool for Differential Diagnosis of Thiazide-Associated Hyponatremia’, Journal of Clinical Endocrinology and Metabolism, 108(9), pp. 2248–2254. Available at: https://doi.org/10.1210/clinem/dgad133.

Arima H et al. (2023) ‘Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus’, Hormone Research in Paediatrics, 96(4), pp. 423–425. Available at: https://doi.org/10.1159/000527139.

Radvanyi, Z. et al. (2023) ‘Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2023.06.23.546282.

Urwyler, Sandrine A. and Karavitaki, Niki (2023) ‘Refractory lactotroph adenomas’, Pituitary, 26(3), pp. 273–277. Available at: https://doi.org/10.1007/s11102-023-01305-8.

Ebrahimi F and Ludvigsson JF (2023) ‘Letter to the editor: Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort’, 77(5). Available at: https://doi.org/10.1097/HEP.0000000000000273.

Gregoriano, Claudia et al. (2023) ‘Burden of disease in patients hospitalised with COVID-19 during the first and second pandemic wave in Switzerland: a nationwide cohort study’, Swiss Medical Weekly, 153(5). Available at: https://doi.org/10.57187/smw.2023.40068.

Zucal, Isabel et al. (2023) ‘Augmentation-Mastopexy: Analysis of 95 Consecutive Patients and Critical Appraisal of the Procedure’, Journal of Clinical Medicine, 12(9). Available at: https://doi.org/10.3390/jcm12093213.

Ebrahimi F and Christ E (2023) ‘Why do patients with hypopituitarism still present an increased mortality?’, Annales d’Endocrinologie, 84(2), pp. 285–290. Available at: https://doi.org/10.1016/j.ando.2023.02.002.

Monnerat S et al. (2023) ‘Prevalence of Admission Hyponatremia in Patients With Diabetes Treated With and Without an SGLT2 inhibitor’, Journal of the Endocrine Society, 7(4), p. bvad011. Available at: https://doi.org/10.1210/jendso/bvad011.

Lengsfeld, Sophia et al. (2023) ‘Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial’, eClinicalMedicine, 57. Available at: https://doi.org/10.1016/j.eclinm.2023.101865.

Lengsfeld, Sophia et al. (2023) ‘Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial’, eClinicalMedicine, 57, p. 101865. Available at: https://doi.org/10.1016/j.eclinm.2023.101865.

Pelouto A et al. (2023) ‘Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia’, European Journal of Endocrinology, 188(3), pp. 322–330. Available at: https://doi.org/10.1093/ejendo/lvad028.

Sailer CO et al. (2023) ‘Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis’, European Journal of Endocrinology, 188(3), pp. 266–272. Available at: https://doi.org/10.1093/ejendo/lvad022.

Workeneh BT et al. (2023) ‘Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice’, Advances in Kidney Disease and Health , 30(2), pp. 85–101. Available at: https://doi.org/10.1053/j.akdh.2022.11.004.

Refardt J et al. (2023) ‘Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial’, Journal of the American Society of Nephrology, 34(2), pp. 322–332. Available at: https://doi.org/10.1681/ASN.2022050623.

Struja, Tristan et al. (2023) ‘Comparison of Cardiovascular Procedure Rates in Patients with Supplementary vs Basic Insurance in Switzerland’, JAMA Network Open, 6(1), p. E2251965. Available at: https://doi.org/10.1001/jamanetworkopen.2022.51965.

Arima H et al. (2023) ‘Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus’, Journal of Clinical Endocrinology and Metabolism, 108(1), pp. 1–3. Available at: https://doi.org/10.1210/clinem/dgac547.

Atila, Cihan et al. (2023) ‘Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial’, The Lancet Diabetes and Endocrinology, 11, pp. 454–464. Available at: https://doi.org/10.1016/s2213-8587(23)00120-1.

Fu, Edouard L., Kutz, Alexander and Desai, Rishi J. (2023) ‘Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown’, Kidney International, 103(1), pp. 30–33. Available at: https://doi.org/10.1016/j.kint.2022.09.012.

Klomp MJ et al. (2023) ‘Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors’, Frontiers in Endocrinology, 14, p. 1184436. Available at: https://doi.org/10.3389/fendo.2023.1184436.

Monnerat, Sophie et al. (2023) ‘Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study—the TREASURE study’, European Journal of Endocrinology, 189, pp. 252–261. Available at: https://doi.org/10.1093/ejendo/lvad108.

Probst, L. et al. (2023) ‘Effects of dulaglutide on alcohol consumption during smoking cessation’, JCI Insight, 8(22). Available at: https://doi.org/10.1172/jci.insight.170419.

Refardt, Julie et al. (2023) ‘Arginine or Hypertonic Saline.Stimulated Copeptin to Diagnose AVP Deficiency’, New England Journal of Medicine, 389(20), pp. 1877–1887. Available at: https://doi.org/10.1056/NEJMoa2306263.

Refardt, Julie, Atila, Cihan and Christ-Crain, Mirjam (2023) ‘New insights on diagnosis and treatment of AVP deficiency’, Reviews in Endocrine and Metabolic Disorders, null. Available at: https://doi.org/10.1007/s11154-023-09862-w.

Rhonheimer, Lena, Refardt, Julie and Christ, Emanuel (2023) ‘Epidemiology and management of neuroendocrine neoplasms of unknown origin: an overview’, Austrian Journal of Clinical Endocrinology and Metabolism, 16, pp. 138–145. Available at: https://doi.org/10.1007/s41969-023-00217-z.

Roth, Sofia et al. (2023) ‘Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver Failure’, Gastro Hep Advances, 2(1), pp. 72–82. Available at: https://doi.org/10.1016/j.gastha.2022.08.006.

Schmidlin, Moira et al. (2023) ‘Improvement of Lung NET Management through Standardized Care—A Swiss Nationwide Observational Study’, Cancers, 15. Available at: https://doi.org/10.3390/cancers15082270.

Arima H et al. (2022) ‘Changing the name of diabetes insipidus’, 25(6). Available at: https://doi.org/10.1007/s11102-022-01276-2.

Borisov AN et al. (2022) ‘No obesity paradox in patients with community-acquired pneumonia – secondary analysis of a randomized controlled trial’, Nutrition and Diabetes, 12(1), p. 12. Available at: https://doi.org/10.1038/s41387-022-00190-7.

Liberale, Luca et al. (2022) ‘Serum circulating sirtuin 6 as a novel predictor of mortality after acute ischemic stroke’, Scientific Reports, 12(1). Available at: https://doi.org/10.1038/s41598-022-23211-y.

Nahum U et al. (2022) ‘Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice’, European Journal of Endocrinology, 187(6), pp. 777–786. Available at: https://doi.org/10.1530/EJE-22-0368.

Working Group for Renaming Diabetes Insipidus et al. (2022) ‘Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus’, Endocrine Connections, 11(11). Available at: https://doi.org/10.1530/EC-22-0378.

Working Group for Renaming Diabetes Insipidus et al. (2022) ‘Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus’, European Journal of Endocrinology, 187(5), pp. P1–P3. Available at: https://doi.org/10.1530/EJE-22-0751.

Atila C et al. (2022) ‘Central diabetes insipidus from a patient’s perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey’, The Lancet Diabetes and Endocrinology, 10(10), pp. 700–709. Available at: https://doi.org/10.1016/S2213-8587(22)00219-4.

Winzeler B et al. (2022) ‘Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort’, Clinical Endocrinology, 97(4), pp. 448–459. Available at: https://doi.org/10.1111/cen.14639.

Arima H et al. (2022) ‘Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus.’ Available at: https://doi.org/10.1111/cen.14819.

Ebrahimi, Fahim et al. (2022) ‘Lifetime risk and health-care burden of diabetic ketoacidosis: A population-based study’, Frontiers in Endocrinology, 13. Available at: https://doi.org/10.3389/fendo.2022.940990.

Atila C et al. (2022) ‘The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study’, Pituitary, 25(4), pp. 636–644. Available at: https://doi.org/10.1007/s11102-022-01240-0.

Gregoriano C et al. (2022) ‘Association of Different Malnutrition Parameters and Clinical Outcomes among COVID-19 Patients: An Observational Study’, Nutrients, 14(16). Available at: https://doi.org/10.3390/nu14163449.

Christ E et al. (2022) ‘Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology’, Swiss Medical Weekly, 152(2930), p. w30197. Available at: https://doi.org/10.4414/SMW.2022.w30197.

Atila C et al. (2022) ‘Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study’, European Journal of Endocrinology, 187(1), pp. 65–74. Available at: https://doi.org/10.1530/EJE-22-0033.

Refardt J et al. (2022) ‘Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients’, European Journal of Endocrinology, 187(1), pp. 209–217. Available at: https://doi.org/10.1530/EJE-22-0023.

Refardt J et al. (2022) ‘Molecular Imaging of Neuroendocrine Neoplasms’, Journal of Clinical Endocrinology and Metabolism, 107(7), pp. E2662–E2670. Available at: https://doi.org/10.1210/clinem/dgac207.

Refardt J et al. (2022) ‘Effect of epigenetic treatment on SST(2) expression in neuroendocrine tumour patients.’, 12(7). Available at: https://doi.org/10.1002/ctm2.957.

Bicvic A et al. (2022) ‘A novel biomarker panel index improves risk stratification after ischemic stroke’, European Stroke Journal, 7(2), pp. 158–165. Available at: https://doi.org/10.1177/23969873221090798.

Christ-Crain M, Refardt J and Winzeler B (2022) ‘Approach to the Patient: ‘Utility of the Copeptin Assay’’, Journal of Clinical Endocrinology and Metabolism, 107(6), pp. 1727–1738. Available at: https://doi.org/10.1210/clinem/dgac070.

Christ E, Wild D and Refardt J (2022) ‘Molecular Imaging in neuroendocrine neoplasias’, Presse Medicale, 51(2), p. 104115. Available at: https://doi.org/10.1016/j.lpm.2022.104115.

Vukajlovic T et al. (2022) ‘Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants’, Journal of Clinical Endocrinology and Metabolism, 107(6), pp. E2581–E2589. Available at: https://doi.org/10.1210/clinem/dgac063.

Wolfisberg S et al. (2022) ‘Call, chosen, HA2T2, ANDC: validation of four severity scores in COVID-19 patients’, Infection, 50(3), pp. 651–659. Available at: https://doi.org/10.1007/s15010-021-01728-0.

Atila, C. et al. (2022) The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-1636018/v1.

Refardt J et al. (2022) ‘Prognostic significance of hyperammonemia in neuroendocrine neoplasm patients with liver metastases’, Endocrine-Related Cancer, 29(5), pp. 241–250. Available at: https://doi.org/10.1530/ERC-21-0346.

Voelkle M et al. (2022) ‘Prevalence of Micronutrient Deficiencies in Patients Hospitalized with COVID-19: An Observational Cohort Study’, Nutrients, 14(9). Available at: https://doi.org/10.3390/nu14091862.

Kaegi-Braun N et al. (2022) ‘Validation of modified GLIM criteria to predict adverse clinical outcome and response to nutritional treatment: A secondary analysis of a randomized clinical trial’, Clinical Nutrition, 41(4), pp. 795–804. Available at: https://doi.org/10.1016/j.clnu.2022.02.009.

Koch D et al. (2022) ‘Derivation and validation of a prediction model to establish nursing-sensitive quality benchmarks in medical inpatients: a secondary data analysis of a prospective cohort study’, Swiss Medical Weekly, 152(11-12), p. w30152. Available at: https://doi.org/10.4414/smw.2022.w30152.